Multi-target-Directed Ligands To Combat Neurodegenerative Diseases

Cited by (1,000)

Items 301–400 of 1,000

1. Pyridoxine-resveratrol hybrids as novel inhibitors of MAO-B with antioxidant and neuroprotective activities for the treatment of Parkinson’s disease
   Wěi Li, Xia Yang, Qing Song, Zhongcheng Cao, Yichun Shi, Yong Deng, Li Zhang · 2020 · Bioorganic Chemistry
2. New deferiprone derivatives as multi-functional cholinesterase inhibitors: design, synthesis and in vitro evaluation
   Martina Bortolami, Fabiana Pandolfi, Daniela De Vita, Camilla Carafa, Antonella Messore, Roberto Di Santo, Marta Feroci, Roberta Costi, Isabella Chiarotto, Donatella Bagetta et al. · 2020 · European Journal of Medicinal Chemistry
3. Halogenated Coumarin–Chalcones as Multifunctional Monoamine Oxidase-B and Butyrylcholinesterase Inhibitors
   Nisha Abdul Rehuman, Jong‐Min Oh, Lekshmi R. Nath, Ahmed Khames, Mohamed Abdelwahab Abdelgawad, Nicola Gambacorta, Orazio Nicolotti, Rakesh Kumar Jat, Hoon Kim, Bijo Mathew · 2021 · ACS Omega
4. A Review of the Recent Advances in Alzheimer’s Disease Research and the Utilization of Network Biology Approaches for Prioritizing Diagnostics and Therapeutics
   Rima Hajjo, Dima A. Sabbah, Osama H. Abusara, Abdel Qader Al Bawab · 2022 · Diagnostics
5. Structure-based inhibition of acetylcholinesterase and butyrylcholinesterase with 2-Aryl-6-carboxamide benzoxazole derivatives: synthesis, enzymatic assay, and in silico studies
   Burak Kuzu, Mehmet Abdullah Alagöz, Yeliz Demir, İlhami Gülçın, Serdar Burmaoğlu, Öztekin Algül · 2024 · Molecular Diversity
6. Structure–activity relationships of novel substituted naphthalene diimides as anticancer agents
   Andrea Milelli, Vincenzo Tumiatti, Marialuisa Micco, Michela Rosini, Guendalina Zuccari, Lizzia Raffaghello, Giovanna Bianchi, Vito Pistoia, José Fernando Díaz, Benet Pera et al. · 2012 · European Journal of Medicinal Chemistry
7. From BACE1 Inhibitor to Multifunctionality of Tryptoline and Tryptamine Triazole Derivatives for Alzheimer’s Disease
   Jutamas Jiaranaikulwanitch, Piyarat Govitrapong, Valery V. Fokin, Opa Vajragupta · 2012 · Molecules
8. 1,2,3,4-Tetrahydrobenzo[h][1,6]naphthyridines as a new family of potent peripheral-to-midgorge-site inhibitors of acetylcholinesterase: Synthesis, pharmacological evaluation and mechanistic studies
   Ornella Di Pietro, Elisabet Viayna, Esther Vicente‐García, Manuela Bartolini, Rosario Ramón, Jordi Juárez‐Jiménez, M. Victòria Clos, Belén Pérez, Vincenza Andrisano, Francisco Javier Luque et al. · 2013 · European Journal of Medicinal Chemistry
9. Interference of a new cyclometallated Pt compound with Cu binding to amyloid-β peptide
   Isabelle Sasaki, Christian Bijani, Sonia Mallet‐Ladeira, Valérie Bourdon, Peter Faller, Christelle Hureau · 2012 · Dalton Transactions
10. Evidence for Inhibition of Lysozyme Amyloid Fibrillization by Peptide Fragments from Human Lysozyme: A Combined Spectroscopy, Microscopy, and Docking Study
    Rajiv K. Kar, Zuzana Gažová, Zuzana Bednáriková, Kamal H. Mroué, Anirban Ghosh, Ruiyan Zhang, Katarina Ulicna, Hans‐Christian Siebert, Nikolay E. Nifantiev, Anirban Bhunia · 2016 · Biomacromolecules
11. Design, synthesis and evaluation of 4-dimethylamine flavonoid derivatives as potential multifunctional anti-Alzheimer agents
    Wen Luo, Ting Wang, Hong Chen, Ya–Chen Yang, Ying Chen, Juan Cen, Songqiang Xie, Chao–Jie Wang · 2016 · European Journal of Medicinal Chemistry
12. Multitargeted Imidazoles: Potential Therapeutic Leads for Alzheimer’s and Other Neurodegenerative Diseases
    Anne‐Sophie Cornec, Ludovica Monti, Jane Kovalevich, Vishruti S. Makani, Michael J. James, Krishna G. Vijayendran, Killian Oukoloff, Yuemang Yao, Virginia M.‐Y. Lee, John Q. Trojanowski et al. · 2017 · Journal of Medicinal Chemistry
13. Novel multi-target directed ligand-based strategies for reducing neuroinflammation in Alzheimer's disease
    Tyler J. Wenzel, Andis Klegeris · 2018 · Life Sciences
14. Investigating alkyl nitrates as nitric oxide releasing precursors of multitarget acetylcholinesterase-monoamine oxidase B inhibitors
    Leonardo Pisani, Rosa Maria Iacobazzi, Marco Catto, Mariagrazia Rullo, Roberta Farina, Nunzio Denora, Saverio Cellamare, Cosimo Altomare · 2018 · European Journal of Medicinal Chemistry
15. Drug Research Meets Network Science: Where Are We?
    Maurizio Recanatini, Chiara Cabrelle · 2020 · Journal of Medicinal Chemistry
16. Two Functions, One Molecule: A Metal‐Binding and a Targeting Moiety to Combat Alzheimer's Disease
    Hureau, Christelle, Sasaki, Isabelle, Gras, Emmanuel, Faller, Peter · 2010 · ChemBioChem
17. Activators of Nrf2 to Counteract Neurodegenerative Diseases
    Rosa Amoroso, Cristina Maccallini, Ilaria Bellezza · 2023 · Antioxidants
18. Synthesis and biological assessment of diversely substituted furo[2,3-b]quinolin-4-amine and pyrrolo[2,3-b]quinolin-4-amine derivatives, as novel tacrine analogues
    Carla Martins, M. Carmo Carreiras, Rafael M. Leon, Cristóbal de los Rı́os, Manuela Bartolini, Vincenza Andrisano, Isabel Iriepa, Ignacio Moraleda, E. Galvez‐Ruano, Manuela E. García et al. · 2011 · European Journal of Medicinal Chemistry
19. Hybrid Compounds
    Andreas Müller‐Schiffmann, Heinrich Sticht, Carsten Korth · 2011 · BioDrugs
20. Discovery of a Novel Series of Phenyl Pyrazole Inner Salts Based on Fipronil as Potential Dual-Target Insecticides
    Dingxin Jiang, Xiaohua Zheng, Guang Shao, Ling Zhang, Hanhong Xu · 2014 · Journal of Agricultural and Food Chemistry
21. Advances in the use of prodrugs for drug delivery to the eye
    Pranjal Taskar, Akshaya Tatke, Soumyajit Majumdar · 2016 · Expert Opinion on Drug Delivery
22. Multi-Target Screening and Experimental Validation of Natural Products from Selaginella Plants against Alzheimer's Disease
    Yin-Hua Deng, Ningning Wang, Zhen‐Xing Zou, Lin Zhang, Kang-Ping Xu, Alex F. Chen, Dongsheng Cao, Gui‐Shan Tan · 2017 · Frontiers in Pharmacology
23. Tacripyrimidines, the first tacrine-dihydropyrimidine hybrids, as multi-target-directed ligands for Alzheimer's disease
    Mourad Chioua, Eleonora Buzzi, Ignacio Moraleda, Isabel Iriepa, Maciej Maj, Artur Wnorowski, Catia Giovannini, Anna Tramarin, Federica Portali, Lhassane Ismaïli et al. · 2018 · European Journal of Medicinal Chemistry
24. Development and therapeutic potential of autotaxin small molecule inhibitors: From bench to advanced clinical trials
    Alexios N. Matralis, Antreas Afantitis, Vassilis Aidinis · 2018 · Medicinal Research Reviews
25. New Hybrids of 4-Amino-2,3-polymethylene-quinoline and p-Tolylsulfonamide as Dual Inhibitors of Acetyl- and Butyrylcholinesterase and Potential Multifunctional Agents for Alzheimer’s Disease Treatment
    Makhaeva, Galina F., Kovaleva, Nadezhda V., Boltneva, Natalia P., Lushchekina, Sofya V., Astakhova, Tatiana Yu., Rudakova, Elena V., Proshin, Alexey N., Serkov, Igor V., Radchenko, Eugene V., Palyulin, Vladimir A. et al. · 2020 · Molecules
26. Structural and Molecular Insight into Piperazine and Piperidine Derivatives as Histamine H3 and Sigma-1 Receptor Antagonists with Promising Antinociceptive Properties
    Katarzyna Szczepańska, Sabina Podlewska, Maria Dichiara, Davide Gentile, Vincenzo Patamia, Niklas Rosier, Denise Mönnich, M. Carmen Ruiz‐Cantero, Tadeusz P. Karcz, Dorota Łażewska et al. · 2021 · ACS Chemical Neuroscience
27. Design, Synthesis, and Bioevaluation of Indole Core Containing 2-Arylidine Derivatives of Thiazolopyrimidine as Multitarget Inhibitors of Cholinesterases and Monoamine Oxidase A/B for the Treatment of Alzheimer Disease
    Muhammad Shahid Nadeem, Jalaluddin Azam Khan, Imran Ahmed Kazmi, Umer Rashid · 2022 · ACS Omega
28. Design, synthesis and in vitro biological activities of coumarin linked 1,3,4-oxadiazole hybrids as potential multi-target directed anti-Alzheimer agents
    Namy George, Bushra Al Sabahi, Majed AbuKhader, Khalid A. Al Balushi, Md Jawaid Akhtar, Shah Alam Khan · 2022 · Journal of King Saud University - Science
29. AI-Driven Polypharmacology in Small-Molecule Drug Discovery
    Mena Abdelsayed · 2025 · International Journal of Molecular Sciences
30. Lacosamide Isothiocyanate-Based Agents: Novel Agents To Target and Identify Lacosamide Receptors
    Ki Duk Park, Pierre Morieux, Christophe Salomé, Steven W. Cotten, Onrapak Reamtong, Claire E. Eyers, Simon J. Gaskell, James P. Stables, Rihe Liu, Harold Kohn · 2009 · Journal of Medicinal Chemistry
31. Synthesis of new N-benzylpiperidine derivatives as cholinesterase inhibitors with β-amyloid anti-aggregation properties and beneficial effects on memory in vivo
    Anna Więckowska, Krzysztof Więckowski, Marek Bajda, Boris Brus, Kinga Sałat, Paulina Czerwińska, Stanislav Gobec, Barbara Filipek, Barbara Malawska · 2015 · Bioorganic & Medicinal Chemistry
32. Evaluation of nicotine and cotinine analogs as potential neuroprotective agents for Alzheimer’s disease
    Jie Gao, Bao-Ling Adam, Alvin V. Terry · 2014 · Bioorganic & Medicinal Chemistry Letters
33. Structure–Activity Relationship Study ofN6-(2-(4-(1H-Indol-5-yl)piperazin-1-yl)ethyl)-N6-propyl-4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine Analogues: Development of Highly Selective D3 Dopamine Receptor Agonists along with a Highly Potent D2/D3 Agonist and Their Pharmacological Characterization
    Mark Johnson, Tamara Antonio, Maarten E. A. Reith, Aloke K. Dutta · 2012 · Journal of Medicinal Chemistry
34. Synthesis and activity towards Alzheimer's disease in vitro: Tacrine, phenolic acid and ligustrazine hybrids
    Guoliang Li, Ge Hong, Xinyu Li, Yan Zhang, Zengping Xu, Lina Mao, Xizeng Feng, Tianjun Liu · 2018 · European Journal of Medicinal Chemistry
35. Inhibition of β-site amyloid precursor protein cleaving enzyme 1 and cholinesterases by pterosins via a specific structure−activity relationship with a strong BBB permeability
    Susoma Jannat, Anand Balupuri, Md Yousof Ali, Seong Su Hong, Chun Whan Choi, Yun‐Hyeok Choi, Jin‐Mo Ku, Woo Jung Kim, Jae Yoon Leem, Ju Eun Kim et al. · 2019 · Experimental & Molecular Medicine
36. Chalcone Derivatives with a High Potential as Multifunctional Antioxidant Neuroprotectors
    Adriana Pérez‐González, Romina Castañeda‐Arriaga, Eduardo Gabriel Guzmán‐López, Luis Felipe Hernández‐Ayala, Annia Galano · 2022 · ACS Omega
37. Synthesis of New Triazole-Based Thiosemicarbazone Derivatives as Anti-Alzheimer’s Disease Candidates: Evidence-Based In Vitro Study
    Fazal Rahim, Hayat Ullah, Muhammad Taha, Rafaqat Hussain, Maliha Sarfraz, Rashid Iqbal, Naveed Iqbal, Shoaib Khan, Syed Adnan Alı Shah, Marzough Aziz Albalawi et al. · 2022 · Molecules
38. Early- and Late-Onset Alzheimer’s Disease: Two Sides of the Same Coin?
    César A. Valdez-Gaxiola, Frida Rosales-Leycegui, Abigail Gaxiola-Rubio, José Miguel Moreno-Ortíz, Luis Eduardo Figuera · 2024 · Diseases
39. Cholinergic and neuroprotective drugs for the treatment of Alzheimer and neuronal vascular diseases. II. Synthesis, biological assessment, and molecular modelling of new tacrine analogues from highly substituted 2-aminopyridine-3-carbonitriles
    Abdelouahid Samadi, Carolina Valderas, Cristóbal de los Rı́os, Ágatha Bastida, Mourad Chioua, Laura González‐Lafuente, Inés Colmena, Luis Gandı́a, Alejandro Romero, Laura del Barrio et al. · 2010 · Bioorganic & Medicinal Chemistry
40. Fine molecular tuning at position 4 of 2H-chromen-2-one derivatives in the search of potent and selective monoamine oxidase B inhibitors
    Leonardo Pisani, Marco Catto, Orazio Nicolotti, Giancarlo Grossi, Mario Di Braccio, Ramón Soto‐Otero, Estefanía Méndez‐Álvarez, Angela Stefanachi, Domenico Gadaleta, Angelo Carotti · 2013 · European Journal of Medicinal Chemistry
41. Multi-target-directed therapeutic potential of 7-methoxytacrine-adamantylamine heterodimers in the Alzheimer's disease treatment
    Zuzana Gažová, Ondřej Soukup, Vendula Šepsová, Katarína Šipošová, Lucie Drtinová, Petr Jost, Katarína Špilovská, Jan Korábečný, Eugenie Nepovimová, Diana Fedunová et al. · 2016 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
42. Synthesis of novel vanillin derivatives: novel multi-targeted scaffold ligands against Alzheimer's disease
    Matteo Scipioni, Graeme Kay, Ian L. Megson, Paul Kong Thoo Lin · 2019 · MedChemComm
43. Probing Multi-Target Action of Phlorotannins as New Monoamine Oxidase Inhibitors and Dopaminergic Receptor Modulators with the Potential for Treatment of Neuronal Disorders
    Su Hui Seong, Pradeep Paudel, Jeong‐Wook Choi, Dong Hyun Ahn, Taek‐Jeong Nam, Hyun‐Ah Jung, Jae Sue Choi · 2019 · Marine Drugs
44. In-vitro evaluation of antioxidant and anticholinesterase activities of novel pyridine, quinoxaline and s-triazine derivatives
    Motakatla Venkata Krishna Reddy, Kandrakonda Yelamanda Rao, Gokanapalli Anusha, Gandla Mahesh Kumar, Amooru Gangaiah Damu, Kakarla Raghava Reddy, Nagaraj P. Shetti, Tejraj Malleshappa Aminabhavi, Peddiahgari Vasu Govardhana Reddy · 2021 · Environmental Research
45. Unveiling the Multitarget Anti-Alzheimer Drug Discovery Landscape: A Bibliometric Analysis
    Anna Sampietro, Francisco Javier Pérez-Areales, Paula Martínez, Elsa M. Arce, Carles Galdeano, Diego Muñoz‐Torrero · 2022 · Pharmaceuticals
46. 8-Hydroxyquinolylnitrones as multifunctional ligands for the therapy of neurodegenerative diseases
    Damijan Knez, Daniel Diez‐Iriepa, Mourad Chioua, Andrea Gottinger, Milica Denic, Fabien Chantegreil, Florian Nachon, Xavier Brazzolotto, Anna Skrzypczak-Wiercioch, A. Meden et al. · 2023 · Acta Pharmaceutica Sinica B
47. The First Dual ChE/FAAH Inhibitors: New Perspectives for Alzheimer's Disease?
    Angela Rampa, Manuela Bartolini, Alessandra Bisi, Federica Belluti, Silvia Gobbi, Vincenza Andrisano, Alessia Ligresti, Vincenzo Di Marzo · 2012 · ACS Medicinal Chemistry Letters
48. Design, synthesis and evaluation of novel 4-dimethylamine flavonoid derivatives as potential multi-functional anti-Alzheimer agents
    Wen Luo, Yabin Su, Hong Chen, Run-Guo Tian, Lei-Peng Su, Yueqiao Wang, Li Yang, Junjie Yue, Chaojie Wang · 2013 · Bioorganic & Medicinal Chemistry
49. Xanthone and Flavone Derivatives as Dual Agents with Acetylcholinesterase Inhibition and Antioxidant Activity as Potential Anti-Alzheimer Agents
    Inês Cruz, Ploenthip Puthongking, Sara M. M. Cravo, Andreia Palmeira, Honorina M. Cidade, Madalena M. M. Pinto, Emı́lia Sousa · 2017 · Journal of Chemistry
50. Multipotent AChE and BACE-1 inhibitors for the treatment of Alzheimer's disease: Design, synthesis and bio-analysis of 7-amino-1,4-dihydro-2 H -isoquilin-3-one derivates
    Xiongjie Zhao, Da-min Gong, Yuren Jiang, Dong Guo, Yao Hui Zhu, Youchao Deng · 2017 · European Journal of Medicinal Chemistry
51. Methylene blue and its analogues as antidepressant compounds
    Anzelle Delport, Brian Herbert Harvey, Anél Petzer, Jacobus Petrus Petzer · 2017 · Metabolic Brain Disease
52. Synthesis and biological evaluation of some 1‐naphthol derivatives as antioxidants, acetylcholinesterase, and carbonic anhydrase inhibitors
    Musa Erdoğan, Leyla Polat Köse, Selçuk Eşsiz, İlhami Gülçın · 2021 · Archiv der Pharmazie
53. Multipotent, Permeable Drug ASS234 Inhibits Aβ Aggregation, Possesses Antioxidant Properties and Protects from Aβ-induced Apoptosis In Vitro
    Irene Bolea, Alejandro Gella, Leticia Monjas, Concepción Pérez, Marı́a Isabel Rodrı́guez-Franco, José Marco‐Contelles, Abdelouahid Samadi, Mercedes Unzeta · 2013 · Current Alzheimer Research
54. Benzothiazole Derivatives as Multifunctional Antioxidant Agents for Skin Damage: Structure–Activity Relationship of a Scaffold Bearing a Five-Membered Ring System
    Ernestine Nicaise Djuidje, Riccardo Barbari, Anna Baldisserotto, Elisa Durini, Sabrina Sciabica, Jan M. Balzarini, Sandra Liekens, Silvia Vertuani, Stefano Manfredini · 2022 · Antioxidants
55. Hybrid Molecules from Xanomeline and Tacrine: Enhanced Tacrine Actions on Cholinesterases and Muscarinic M1Receptors
    Lei Fang, Sabine Jumpertz, Yihua Zhang, Dorothea Appenroth, Christian Fleck, Klaus Mohr, Christian Tränkle, Michael W. Decker · 2010 · Journal of Medicinal Chemistry
56. Chiral ruthenium(ii) complexes with phenolic hydroxyl groups as dual poisons of topoisomerases I and IIα
    Pingyu Zhang, Jinquan Wang, Huaiyi Huang, Liping Qiao, Liang‐Nian Ji, Hui Chao · 2013 · Dalton Transactions
57. Effects of a tacrine-8-hydroxyquinoline hybrid (IQM-622) on Aβ accumulation and cell death: Involvement in hippocampal neuronal loss in Alzheimer's disease
    Desireé Antequera, Marta Bolós, Carlos Spuch, Consuelo Pascual, Isidró Ferrer, María Isabel Fernández‐Bachiller, Marı́a Isabel Rodrı́guez-Franco, Eva Carro · 2012 · Neurobiology of Disease
58. Synthesis, cytotoxicity and molecular modelling studies of new phenylcinnamide derivatives as potent inhibitors of cholinesterases
    Aamer Saeed, Parvez Ali Mahesar, Sumera Zaib, Muhammad Sirab Khan, Abdul Matin, Mohammad Shahid, Jamshed Iqbal · 2014 · European Journal of Medicinal Chemistry
59. 7-Methoxytacrine-p-Anisidine Hybrids as Novel Dual Binding Site Acetylcholinesterase Inhibitors for Alzheimer’s Disease Treatment
    Jan Korábečný, Martin Andrš, Eugenie Nepovimová, Rafael Doležal, Katerina Babkova, Anna Horova, David Maliňák, Eva Mezeiová, Lukáš Górecki, Vendula Šepsová et al. · 2015 · Molecules
60. Induction of heat shock proteins in differentiated human neuronal cells following co-application of celastrol and arimoclomol
    Catherine A.S. Deane, Ian R. Brown · 2016 · Cell Stress and Chaperones
61. Network Analysis of Drug–target Interactions: A Study on FDA-approved New Molecular Entities Between 2000 to 2015
    Hui-Heng Lin, Lele Zhang, Ru Yan, Jin‐Jian Lu, Hu Yuanjia · 2017 · Scientific Reports
62. Multifunctional Hybrid Sulfonamides as Novel Therapeutic Agents for Alzheimer’s Disease
    Rayala Swetha, Devendra Kumar, Sukesh Kumar Gupta, Ankit Ganeshpurkar, Ravi Singh, Gopichand Gutti, Dileep Kumar, Srabanti Jana, Sairam Krishnamurthy, Sushil Kumar Singh · 2019 · Future Medicinal Chemistry
63. The Dual-Active Histamine H3 Receptor Antagonist and Acetylcholine Esterase Inhibitor E100 Alleviates Autistic-Like Behaviors and Oxidative Stress in Valproic Acid Induced Autism in Mice
    Nermin Eissa, Sheikh Azimullah, Petrilla Jayaprakash, Richard L. Jayaraj, David Reiner‐Link, Shreesh Kumar Ojha, Rami Beiram, Holger Stark, Dorota Łażewska, Katarzyna Kieć‐Kononowicz et al. · 2020 · International Journal of Molecular Sciences
64. Design, synthesis and evaluation of novel dimethylamino chalcone-O-alkylamines derivatives as potential multifunctional agents against Alzheimer’s disease
    Zhipei Sang, Qing Song, Zhongcheng Cao, Yong Deng, Zhenghuai Tan, Li Zhang · 2021 · European Journal of Medicinal Chemistry
65. Polypharmacological Approaches for CNS Diseases: Focus on Endocannabinoid Degradation Inhibition
    Alessandro Papa, Silvia Pasquini, Chiara Contri, Sandra Gemma, Giuseppe Campiani, Stefania Butini, Katia Varani, Fabrizio Vincenzi · 2022 · Cells
66. Mechanistic Insights for Drug Repurposing and the Design of Hybrid Drugs for Alzheimer’s Disease
    Padhi, Dikshaa, Govindaraju, Thimmaiah · 2022 · Journal of Medicinal Chemistry
67. New Dual Small Molecules for Alzheimer’s Disease Therapy Combining Histamine H ₃ Receptor (H3R) Antagonism and Calcium Channels Blockade with Additional Cholinesterase Inhibition
    Malek, Rim, Arribas, Raquel L., Palomino-Antolin, Alejandra, Totoson, Perle, Demougeot, Celine, Kobrlova, Tereza, Soukup, Ondrej, Iriepa, Isabel, Moraleda, Ignacio, Diez-Iriepa, Daniel et al. · 2019 · Journal of Medicinal Chemistry
68. Interaction of (benzylidene-hydrazono)-1,4-dihydropyridines with β-amyloid, acetylcholine, and butyrylcholine esterases
    Vildan Alptüzün, Michaela Prinz, Verena Hörr, Josef Scheiber, Krzysztof Radacki, Adyary Fallarero, Pia Maarit Vuorela, Bernd Engels, Holger Braunschweig, Erçin Erciyas et al. · 2010 · Bioorganic & Medicinal Chemistry
69. Design and synthesis of novel indole-chalcone fibrates as lipid lowering agents
    Koneni V. Sashidhara, Ranga Prasad Dodda, Ravi Sonkar, Gopala Reddy Palnati, Gitika Bhatia · 2014 · European Journal of Medicinal Chemistry
70. Rational Design of Novel Selective Dual-Target Inhibitors of Acetylcholinesterase and Monoamine Oxidase B as Potential Anti-Alzheimer’s Disease Agents
    Yixiang Xu, Jian Zhang, Huan Wang, Fei Mao, Keting Bao, Wenwen Liu, Jin Zhu, Xiaokang Li, Haiyan Zhang, Jian Li · 2018 · ACS Chemical Neuroscience
71. Chronic Dyrk1 Inhibition Delays the Onset of AD-Like Pathology in 3xTg-AD Mice
    Ramón Velázquez, Bessie Meechoovet, A. Ow, Christopher Foley, Arthur Y. Shaw, Breland E. Smith, Salvatore Oddo, Christopher Hulme, Travis L. Dunckley · 2019 · Molecular Neurobiology
72. Donecopride, a Swiss army knife with potential against Alzheimer's disease
    Christophe Rochais, Cédric Lecoutey, Katia Hamidouche, Patrizia Giannoni, Florence Gaven, Eleazere Cem, Serge M. Mignani, Kévin Baranger, Thomas Fréret, Joël Bockaert et al. · 2019 · British Journal of Pharmacology
73. Schiff Bases of Pioglitazone Provide Better Antidiabetic and Potent Antioxidant Effect in a Streptozotocin–Nicotinamide-Induced Diabetic Rodent Model
    Hafiza Rabia Afzal, Najm ul Hassan Khan, Kishwar Sultana, Aisha Mobashar, Aqsa Lareb, Ayesha Khan, Abrashim Gull, Hasan Afzaal, Muhammad Tariq Khan, Muhammad Rizwan et al. · 2021 · ACS Omega
74. Molecular Insights into Therapeutic Potentials of Hybrid Compounds Targeting Alzheimer’s Disease
    Ankit Jana, Arkadyuti Bhattacharjee, Sabya Sachi Das, Avani Srivastava, Akshpita Choudhury, Rahul Bhattacharjee, Swagata De, Asma Perveen, Danish Iqbal, Piyush Kumar Gupta et al. · 2022 · Molecular Neurobiology
75. Discovery of 3-Arylcoumarin-tetracyclic Tacrine Hybrids as Multifunctional Agents against Parkinson?s Disease
    Koneni V. Sashidhara, Ram K. Modukuri, Pooja Jadiya, K. Bhaskara Rao, Tanuj Sharma, Rizwanul Haque, Deependra Kumar Singh, Dibyendu Banerjee, Mohammad Imran Siddiqi, Aamir Nazir · 2014 · ACS Medicinal Chemistry Letters
76. Development of Dual Inhibitors against Alzheimer’s Disease Using Fragment-Based QSAR and Molecular Docking
    Manisha Goyal, Jaspreet Kaur Dhanjal, Sukriti Goyal, Chetna Tyagi, Rabia Hamid, Abhinav Grover · 2014 · BioMed Research International
77. Insight into the Functional and Structural Properties of 3‐Arylcoumarin as an Interesting Scaffold in Monoamine Oxidase B Inhibition
    María João Matos, Santiago Vilar, Verónica García‐Morales, Nicholas P. Tatonetti, Eugenio Uriarte, Lourdes Santana, Dolores Viña · 2014 · ChemMedChem
78. Design, synthesis, in silico and in vitro screening of 1,2,4-thiadiazole analogues as non-peptide inhibitors of beta-secretase
    Archana S. Gurjar, Vincenza Andrisano, Angela De Simone, Vinay S. Velingkar · 2014 · Bioorganic Chemistry
79. Design, synthesis, and bioevaluation of benzamides: Novel acetylcholinesterase inhibitors with multi-functions on butylcholinesterase, Aβ aggregation, and β-secretase
    Da‐Yong Peng, Qi Sun, Xiao‐Lei Zhu, Hong‐Yan Lin, Qiong Chen, Ningxi Yu, Wen‐Chao Yang, Guang‐Fu Yang · 2012 · Bioorganic & Medicinal Chemistry
80. Development of a Highly Potent D2/D3 Agonist and a Partial Agonist from Structure–Activity Relationship Study of N6-(2-(4-(1H-Indol-5-yl)piperazin-1-yl)ethyl)-N6-propyl-4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine Analogues: Implication in the Treatment of Parkinson’s Disease
    Banibrata Das, Seenuvasan Vedachalam, Dan Luo, Tamara Antonio, Maarten E. A. Reith, Aloke K. Dutta · 2015 · Journal of Medicinal Chemistry
81. Novel multi-targeted agents for Alzheimer's disease: Synthesis, biological evaluation, and molecular modeling of novel 2-[4-(4-substitutedpiperazin-1-yl)phenyl]benzimidazoles.
    Keriman Ozadali-Sari, Tuba Tüylü Küçükkılınç, Beyza Ayazgok, A. Balkan, Oya Unsal-Tan · 2017 · Bioorganic chemistry (Print)
82. Novel Multitarget Directed Triazinoindole Derivatives as Anti-Alzheimer Agents
    Dushyant V. Patel, Nirav R. Patel, Ashish M. Kanhed, Sagar P. Patel, Anshuman Sinha, Deep D. Kansara, Annie R. Mecwan, Sarvangee B. Patel, Pragnesh N. Upadhyay, Kishan B. Patel et al. · 2019 · ACS Chemical Neuroscience
83. Recent advances in multitarget-directed ligands targeting G-protein-coupled receptors
    Hongguang Ma, Boshi Huang, Yan Zhang · 2020 · Drug Discovery Today
84. Rational drug design strategies for the development of promising multi-target directed indole hybrids as Anti-Alzheimer agents
    Namy George, Md Jawaid Akhtar, Khalid A. Al Balushi, Shah Alam Khan · 2022 · Bioorganic Chemistry
85. ‘Click’ D1 receptor agonists with a 5-HT1A receptor pharmacophore producing D2 receptor activity
    Jing Zhang, Hai Zhang, Wenxian Cai, Lei-Ping Yu, Xuechu Zhen, Ao Zhang · 2009 · Bioorganic & Medicinal Chemistry
86. Unveiling the multifaceted bioactivity of copper( ii )–Schiff base complexes: a comprehensive study of antioxidant, anti-bacterial, anti-inflammatory, enzyme inhibition and cytotoxic potentials with DFT insights
    T.M. Dhanya, M.R. Prathapachandra Kurup, K.J. Rajimon, G. Anjali Krishna, Jibin K. Varughese, Kozhiparambil Gopalan Raghu, Sachin Philip, K. M. Divya, Maria Augustine, Puzhavoorparambil Velayudhan Mohanan · 2025 · Dalton Transactions
87. Bis(propyl)-cognitin protects against glutamate-induced neuro-excitotoxicity via concurrent regulation of NO, MAPK/ERK and PI3-K/Akt/GSK3β pathways
    Shengquan Hu, Wei Cui, Shinghung Mak, Jing Tang, Chung‐Lit Choi, Yuan‐Ping Pang, Yifan Han · 2013 · Neurochemistry International
88. Bis(7)‐tacrine Derivatives as Multitarget‐Directed Ligands: Focus on Anticholinesterase and Antiamyloid Activities
    María Laura Bolognesi, Manuela Bartolini, Francesca Mancini, Gianpaolo Chiriano, Luisa Ceccarini, Michela Rosini, Andrea Milelli, Vincenzo Tumiatti, Vincenza Andrisano, Carlo Melchiorre · 2010 · ChemMedChem
89. Application of BACE1 immobilized enzyme reactor for the characterization of multifunctional alkaloids from Corydalis cava (Fumariaceae) as Alzheimer's disease targets
    Jakub Chlebek, Angela De Simone, Anna Hošťálková, Lubomı́r Opletal, Concepción Pérez, Daniel I. Pérez, Lucie Havlíková, Lucie Cahlíková, Vincenza Andrisano · 2016 · Fitoterapia
90. Further Optimization and Evaluation of Bioavailable, Mixed-Efficacy μ-Opioid Receptor (MOR) Agonists/δ-Opioid Receptor (DOR) Antagonists: Balancing MOR and DOR Affinities
    Aubrie A. Harland, Larisa Yeomans, Nicholas W. Griggs, Jessica P. Anand, Irina D. Pogozheva, Emily M. Jutkiewicz, John R. Traynor, Henry I. Mosberg · 2015 · Journal of Medicinal Chemistry
91. The dual-acting AChE inhibitor and H3 receptor antagonist UW-MD-72 reverses amnesia induced by scopolamine or dizocilpine in passive avoidance paradigm in rats
    Bassem Shaban Sadek, Nadia Khan, Fouad H. Darras, Steffen Pockes, Michael W. Decker · 2016 · Physiology & Behavior
92. Tetrahydropyranodiquinolin-8-amines as new, non hepatotoxic, antioxidant, and acetylcholinesterase inhibitors for Alzheimer's disease therapy
    Youssef Dgachi, Olga Sokolov, Vincent Luzet, Justyna Godyń, Dawid Panek, Alexandre Bonet, Hélène Martin, Isabel Iriepa, Ignacio Moraleda, Cristina García‐Iriepa et al. · 2016 · European Journal of Medicinal Chemistry
93. A novel class of multitarget anti-Alzheimer benzohomoadamantane‒chlorotacrine hybrids modulating cholinesterases and glutamate NMDA receptors
    Francisco Javier Pérez-Areales, Andreea L. Turcu, Marta Barniol‐Xicota, Caterina Pont, Deborah Pivetta, Alba Espargaró, Manuela Bartolini, Angela De Simone, Vincenza Andrisano, Belén Pérez et al. · 2019 · European Journal of Medicinal Chemistry
94. Centrally Active Multitarget Anti-Alzheimer Agents Derived from the Antioxidant Lead CR-6
    Francisco Javier Pérez-Areales, María Garrido, Ester Aso, Manuela Bartolini, Angela De Simone, Alba Espargaró, Tiziana Ginex, Raimon Sabaté, Belén Pérez, Vincenza Andrisano et al. · 2020 · Journal of Medicinal Chemistry
95. Unconventional PROTACs for Targeted Protein Degradation in Cancer Therapy
    Xu Zhang, Zhangzhi Song, Xinyu Zhang, Jianhua Zou, Guocan Yu, Xiaoyuan Shawn Chen, Sheng Wang · 2025 · Angewandte Chemie International Edition
96. (Thiazol-2-yl)hydrazone derivatives from acetylpyridines as dual inhibitors of MAO and AChE: synthesis, biological evaluation and molecular modeling studies
    Melissa D’Ascenzio, Paola Chimenti, Maria Concetta Gidaro, Celeste De Monte, Daniela De Vita, Arianna Granese, Luigi Scipione, Roberto Di Santo, Giosuè Costa, Stefano Alcaro et al. · 2015 · Journal of Enzyme Inhibition and Medicinal Chemistry
97. Vitamin D supplements: a novel therapeutic approach for Alzheimer patients
    Cédric Annweiler, Spyridon Ν. Karras, Panagiotis G. Anagnostis, Olivier Beauchet · 2014 · Frontiers in Pharmacology
98. Synthesis and Evaluation of Paeonol Derivatives as Potential Multifunctional Agents for the Treatment of Alzheimer’s Disease
    An Zhou, Hongfei Wu, Jian Pan, Xuncui Wang, Jiaming Li, Zeyu Wu, Ailing Hui · 2015 · Molecules
99. Semisynthesis and biological evaluation of prenylated resveratrol derivatives as multi-targeted agents for Alzheimer’s disease
    Thanchanok Puksasook, Shinya Kimura, Sarin Tadtong, Jutamas Jiaranaikulwanitch, Jaturong Pratuangdejkul, Worawan Kitphati, Khanit Suwanborirux, Naoki Saito, Veena S. Nukoolkarn · 2017 · Journal of Natural Medicines
100. Protective effects of Forsythoside A on amyloid beta-induced apoptosis in PC12 cells by downregulating acetylcholinesterase
     Xiaojuan Yan, Tinggui Chen, Liwei Zhang, Huizhi Du · 2017 · European Journal of Pharmacology